1009 related articles for article (PubMed ID: 19207663)
21. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.
Tremaine WJ; Timmons LJ; Loftus EV; Pardi DS; Sandborn WJ; Harmsen WS; Thapa P; Zinsmeister AR
Aliment Pharmacol Ther; 2007 Jun; 25(12):1435-41. PubMed ID: 17539983
[TBL] [Abstract][Full Text] [Related]
22. [Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998-2000].
Urne FU; Paerregaard A
Ugeskr Laeger; 2002 Dec; 164(49):5810-4. PubMed ID: 12523226
[TBL] [Abstract][Full Text] [Related]
23. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
[TBL] [Abstract][Full Text] [Related]
24. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
[TBL] [Abstract][Full Text] [Related]
25. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
26. Defense mechanisms in inflammatory bowel disease.
Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
[TBL] [Abstract][Full Text] [Related]
27. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
29. Coeliac disease associated with psoriasis.
Birkenfeld S; Dreiher J; Weitzman D; Cohen AD
Br J Dermatol; 2009 Dec; 161(6):1331-4. PubMed ID: 19785615
[TBL] [Abstract][Full Text] [Related]
30. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
31. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin.
Mishkin B; Yalovsky M; Mishkin S
Am J Gastroenterol; 1997 Jul; 92(7):1148-53. PubMed ID: 9219788
[TBL] [Abstract][Full Text] [Related]
32. Discriminant histological features in the diagnosis of chronic idiopathic inflammatory bowel disease: analysis of a large dataset by a novel data visualisation technique.
Cross SS; Harrison RF
J Clin Pathol; 2002 Jan; 55(1):51-7. PubMed ID: 11825925
[TBL] [Abstract][Full Text] [Related]
33. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion.
Clancy R; Ren Z; Turton J; Pang G; Wettstein A
Dig Liver Dis; 2007 May; 39(5):445-51. PubMed ID: 17317344
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
[TBL] [Abstract][Full Text] [Related]
35. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
37. Non-calculus suppurative cholangitis in Danish patients with inflammatory bowel disease.
Rasmussen HH; Nørgård B; Olsen ML; Fonager K; Sørensen HT
Hepatogastroenterology; 2005; 52(61):115-8. PubMed ID: 15783009
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
40. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
